Search

everythinglearnresearchcommunity

for

Search:↓

A lotion with minoxidil, hydrocortisone butyrate, and 17a-estradiol can improve or stabilize Frontal Fibrosing Alopecia in some cases, but there's no universally-accepted treatment yet.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Intralesional triamcinolone acetonide helps regrow eyebrows in patients with frontal fibrosing alopecia.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

FOL-005, a hair growth promoter, acts locally on mouse skin where injected and could be a promising hair loss treatment.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Frontal fibrosing alopecia can be diagnosed by examining facial areas and treated with specific medications to stop its progression.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Baricitinib may effectively treat nail changes in alopecia areata.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

Low fucosylation boosts stem cell growth in the eye.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.